The Advances in Genome Biology and Technology (AGBT) meeting will be held at the JW Marriott Grande Lakes from February 10-13. We look forward to being there, and we hope you’ll drop by to attend our workshop, software demo and poster session for a peek at our solutions.
Our workshop will include a presentation from Dr. Chris Mason, an associate professor at Weill Cornell Medicine whose work has been recognized with awards from the NIH and the CDC and has been featured in Nature, Science, The New York Times, the Wall Street Journal, and more. His 100-plus peer-reviewed papers have been cited more than 5,500 times; he has also co-founded three biotechnology startup companies and serves as an advisor to several others. You don’t want to miss his talk!
Below is a quick glance at QIAGEN highlights on the AGBT agenda. We really hope to see you there!
Workshop (complimentary lunch provided)
Thursday, February 11, 12:05 p.m. – 1:05 p.m.
Coquina North
Presenter: Dr. Chris Mason, Associate Professor at Weill Cornell Medicine
“Targeted RNA Sequencing, Urban Metagenomics, and Astronaut Genomics”
In this presentation, Mason will cover the QIAseq Targeted RNA Panel beta testing, QIAGEN’s sample-to-insight solution for metagenomics sequencing, as demonstrated in the MetaSUB project. He will also discuss his latest endeavor, a comprehensive genomic study of the impact of spaceflight on the human body. Astronaut Scott Kelly will be studied during the course of his year-long stay at the International Space Study, as will his twin brother, Mark Kelly, a former NASA astronaut who will remain on earth. Check out more about this study on NPR.
Poster Presentation: Metagenomics Sample to Insight: MetaSUB 2.0
Thursday, February 11, 5-7 p.m.
Friday, February 12, 4:45-6:45 p.m.
Coquina North
Presenters: Nan Fang & Rumeysa Akinci-Tolun
Metagenomics Sample to Insight: “Ribosomal RNA Depletion from Single-cell RNA-Sequencing Library”
Software Demo Session
Thursday, February 11, 5-7 p.m.
Coquina North
Presenter: Sohela Shah
Ingenuity Variant Analysis, leveraging the Knowledge Base and HGMD, achieves over 30x enrichment in biologically relevant variants from whole genome and exome sequence data from patients with rare disease.
Demo Sessions & Complimentary refreshments
Thursday, February 11 – Saturday, February 13
Del Lago 4
Thursday, February 11 from 10 a.m.-7 p.m.
Friday, February 12 from 10 a.m.-7 p.m.
Saturday, February 13 from 9 a.m.-2 p.m.
For additional updates on QIAGEN at AGBT, please visit the Biomarker Insights blog.
QIAGEN is pleased to sponsor AGBT 2016 and we’re looking forward to seeing you in Orlando.
More information